reference/351038

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/351038

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	2011
issn	1527-7755 0732-183X
issueIdentifier	15
pageRange	2006-2011
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	2006
bibliographicCitation	Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Pater JL; National Cancer Institute of Canada Clinical Trials Group MA.17. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17. J Clin Oncol. 2007 May 20;25(15):2006–11. doi: 10.1200/jco.2006.09.4482. PMID: 17452676.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b20786bac79c17eab960357dbc3baae4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_809519549ee5b2f8852b594e86b1620c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76d373df9ddc7bbfe682f5cb7fabbf69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea611f0eccc997f0c8bdc1099e89c46b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cca395ed64d00be4d113f25b234e19a2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d002785f7ceef09a3cefc3cff243bfe9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cd6c3eb26d810f2aa42783c8b47db8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1df524b6afd9705c36ceaa124717a549 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0515f01d5f6f72b88acbc392c5f0cbff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b5ae5620267f178d26cf6aad7618dc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2937c07629da2d58a4ed267a07a87870 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_552e61e6d5b54ca7fd2c0655b98cc940 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_134283d3f6632da66e67387cdd7d0e8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3701-9250 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1774a80c47c4f6471756c460fa2275d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06defff03cadbd85aee462f5570a4ce1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb61651bf7a2f7a75d2f99825020d513 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f6d15ed6896798e097965b60c782880 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49e8bcef52fb29714defd4cf548b29f3
date	2007-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17452676 https://doi.org/10.1200/jco.2006.09.4482
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17
discusses	http://id.nlm.nih.gov/mesh/M0021911 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M0018586 http://id.nlm.nih.gov/mesh/M0238999 http://id.nlm.nih.gov/mesh/M000640349 http://id.nlm.nih.gov/mesh/M0018613 http://id.nlm.nih.gov/mesh/M0021024
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011960Q000378 http://id.nlm.nih.gov/mesh/D011980Q000378 http://id.nlm.nih.gov/mesh/D001943Q000378 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000077289 http://id.nlm.nih.gov/mesh/D009570Q000008 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D010919 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D002170Q000453 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D014230Q000008 http://id.nlm.nih.gov/mesh/D017024 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000077384 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D017698 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D013629Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2187 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3902 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6d00df506eed78175933b5ecde287c64 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136182740 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129769972 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129138006

Total number of triples: 79.